Clinica Angloamericana

Lima Lima 27

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Coronary Artery Disease (CAD), Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With, Geographic Atrophy, Giant Cell Glioblastoma, Glioblastoma, Glioblastoma With Oligodendroglial Component, Gliosarcoma, Glucocorticoid-induced Osteoporosis, Idiopathic Parkinson's Disease, Lupus, Metastatic Breast Cancer

Studies at this site

• Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02) — Completed
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX — Completed
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed
• A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) — Completed
• MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist — Completed